Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project.

By R. M. Conroy, K. Pyörälä, A. P. Fitzgerald, S. Sans, A. Menotti, G. De Backer, D. de Bacquer, P. Ducimetière, P. Jousilahti, U. Keil and 9 more. European Heart Journal, 2003

5,364 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Public Health, Environmental and Occupational Health, Surgery

View Paper: https://www.semanticscholar.org/paper/6119704e002c105ddaba35663927b0a54dc659b0

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. P. Ridker
2. Ralph B. D’Agostino
3. Michael J. Pencina
4. N. Rifai
5. I. Graham
6. T. Ivanova
7. Philippe van de Borne
8. Alberico L. Catapano

In Public Health, Environmental and Occupational Health

1. I. Graham
2. T. Ivanova
3. I. McInnes
4. N. Rifai
5. P. Nilsson
6. I. Neeland

In Surgery

1. P. Ridker
2. I. Graham
3. N. Rifai
4. Philippe van de Borne
5. Michael J. Pencina
6. T. Ivanova
7. Nancy R. Cook
8. G. Bradwin

Citations in the corpus

• 2016 European Guidelines on cardiovascular disease prevention in clinical practice. (2016, background): “Recommendation for influenza vaccination Recommendation Classa Levelb Ref c Annual vaccination may be considered in patients with established CVD. IIb C 151–154 aClass of recommendation. bLevel of evidence. cReference(s) supporting recommendations.”
• Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. (2007, neutral): “Hypertension 597 (38) 502 (29) Diabetes 76 (5) 50 ( 3 )”
• 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the preventionof sudden cardiac death (2015, neutral): “IIa C 179, 786 CMR ¼ cardiac magnetic resonance; ECG ¼ electrocardiogram; SCD ¼ sudden cardiac death; SCORE ¼ Systematic Coronary Risk Evaluation.787 aClass of recommendation. bLevel of evidence. cReference(s) supporting recommendations.”
• Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study. (2004, methodology): “Although prediction algorithms developed by Framingham investigators have been widely adopted to formulate clinical guidelines in the United States and elsewhere,(12-14) the Framingham functions have overestimated CHD risk in some populations, leading to concern that it is not appropriate to general”
• Development and Validation of the American Heart Association Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) Equations (2023, background): “2,34 ASCVD included coronary heart disease (CHD: myocardial infarction and fatal CHD) and stroke as a composite outcome similar to the PCEs.”